Role of NLRP3 inflammasomes in atherosclerosis

Journal of Atherosclerosis and Thrombosis

Volumn 24, Issue 5, 2017, Pages 443-451

  Karasawa, Tadayoshi ^a   Takahashi, Masafumi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cholesterol; Cytokines; Inflammation; Interleukin 1; Leukocytes

Indexed keywords

7 OXOCHOLESTEROL; ADENOSINE TRIPHOSPHATE; CALCIUM PHOSPHATE; CATHEPSIN B; CERAMIDE; CRYOPYRIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR; HYDROXYAPATITE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; SATURATED FATTY ACID; URATE; INFLAMMASOME;

ABDOMINAL AORTIC ANEURYSM; ATHEROSCLEROSIS; AUTOINFLAMMATORY DISEASE; AUTOPHAGY; CINCA SYNDROME; EXOCYTOSIS; HUMAN; INFLAMMATION; LYMPHOCYTIC INFILTRATION; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; PYROPTOSIS; REVIEW; TRANSCRIPTION REGULATION; UBIQUITINATION; UPREGULATION; ANIMAL; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; HUMANS; INFLAMMASOMES; INFLAMMATION; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN;

EID: 85018941706     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.RV17001     Document Type: Review

References (52)

1. Tall AR and Yvan-Charvet L: Cholesterol, inflammation and innate immunity. Nat Rev Immunol, 2015; 15: 104-116
2. Bennett MR, Sinha S and Owens GK: Vascular Smooth Muscle Cells in Atherosclerosis. Circ Res, 2016; 118: 692-702
3. Weber C and Noels H: Atherosclerosis: current pathogenesis and therapeutic options. Nat Med, 2011; 17: 1410-1422
4. Libby P, Lichtman AH and Hansson GK: Immune effec-tor mechanisms implicated in atherosclerosis: from mice to humans. Immunity, 2013; 38: 1092-1104
5. Nagasawa SY, Ohkubo T, Masaki K, Barinas-Mitchell E, Miura K, Seto T, El-Saed A, Kadowaki T, Willcox BJ, Edmundowicz D, Kadota A, Evans RW, Kadowaki S, Fujiyoshi A, Hisamatsu T, Bertolet MH, Okamura T, Nakamura Y, Kuller LH, Ueshima H, Sekikawa A and Group E-JS: Associations between inflammatory markers and subclinical atherosclerosis in middle-aged white, Jap-anese-American and Japanese men: The ERA-JUMP Study. J Atheroscler Thromb, 2015; 22: 590-598
6. Kumakura H, Fujita K, Kanai H, Araki Y, Hojo Y, Kasama S, Iwasaki T, Ichikawa S, Nakashima K and Min-ami K: High-sensitivity C-reactive protein, lipoprotein(a) and homocysteine are risk factors for coronary artery disease in Japanese patients with peripheral arterial disease. J Atheroscler Thromb, 2015; 22: 344-354
7. Pradeu T and Cooper EL: The danger theory: 20 years later. Front Immunol, 2012; 3: 287
8. Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol, 1994; 12: 991-1045
9. Takeuchi O and Akira S: Pattern recognition receptors and inflammation. Cell, 2010; 140: 805-820
10. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V and Latz E: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature, 2010; 464: 1357-1361
11. Usui F, Shirasuna K, Kimura H, Tatsumi K, Kawashima A, Karasawa T, Hida S, Sagara J, Taniguchi S and Takahashi M: Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice. Biochem Biophys Res Commun, 2012; 425: 162-168
12. Gage J, Hasu M, Thabet M and Whitman SC: Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice. Can J Cardiol, 2012; 28: 222-229
13. － mice. FEBS J, 2015; 282: 2327-2338
14. β. Mol Cell, 2002; 10: 417-426
15. β.J Biol Chem, 1989; 264: 5323-5326
16. β converting enzyme. Science, 1997; 275: 206-209
17. Lamkanfi M and Dixit VM: Mechanisms and functions of inflammasomes. Cell, 2014; 157: 1013-1022
18. Kayagaki N, Stowe IB, Lee BL, O’Rourke K, Anderson K, Warming S, Cuellar T, Haley B, Roose-Girma M, Phung QT, Liu PS, Lill JR, Li H, Wu J, Kummerfeld S, Zhang J, Lee WP, Snipas SJ, Salvesen GS, Morris LX, Fitzgerald L, Zhang Y, Bertram EM, Goodnow CC and Dixit VM: Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature, 2015; 526: 666-671
19. Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F and Shao F: Cleavage of GSDMD by inflammatory caspases determines pyrop-totic cell death. Nature, 2015; 526: 660-665
20. β release depends upon membrane per-meabilisation. Cell Death Differ, 2016; 23: 1219-1231
21. Mariathasan S, Weiss DS, Newton K, McBride J, O’Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM and Dixit VM: Cryopyrin activates the inflammasome in response to toxins and ATP. Nature, 2006; 440: 228-232
22. Martinon F, Petrilli V, Mayor A, Tardivel A and Tschopp J: Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature, 2006; 440: 237-241
23. Guo H, Callaway JB and Ting JP: Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med, 2015; 21: 677-687
24. ＋ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity, 2013; 38: 1142-1153
25. He Y, Hara H and Nunez G: Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends Biochem Sci, 2016; 41: 1012-1021
26. Juliana C, Fernandes-Alnemri T, Kang S, Farias A, Qin F and Alnemri ES: Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J Biol Chem, 2012; 287: 36617-36622
27. Py BF, Kim MS, Vakifahmetoglu-Norberg H and Yuan J: Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol Cell, 2013; 49: 331-338
28. Hoffman HM, Mueller JL, Broide DH, Wanderer AA and Kolodner RD: Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoin-flammatory syndrome and Muckle-Wells syndrome. Nat Genet, 2001; 29: 301-305
29. Yajima N, Takahashi M, Morimoto H, Shiba Y, Takahashi Y, Masumoto J, Ise H, Sagara J, Nakayama J, Taniguchi S and Ikeda U: Critical role of bone marrow apoptosis-asso-ciated speck-like protein, an inflammasome adaptor molecule, in neointimal formation after vascular injury in mice. Circulation, 2008; 117: 3079-3087
30. Ⅱ-induced aortic aneurysm. Arterioscler Thromb Vasc Biol, 2015; 35: 127-136
31. Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J, Hongo M, Noda T, Nakayama J, Sagara J, Taniguchi S and Ikeda U: Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation, 2011; 123: 594-604
32. Komada T, Usui F, Shirasuna K, Kawashima A, Kimura H, Karasawa T, Nishimura S, Sagara J, Noda T, Taniguchi S, Muto S, Nagata D, Kusano E and Takahashi M: ASC in Renal Collecting Duct Epithelial Cells Contributes to Inflammation and Injury after Unilateral Ureteral Obstruction. Am J Pathol, 2014; 184: 1287-1298
33. Komada T, Usui F, Kawashima A, Kimura H, Karasawa T, Inoue Y, Kobayashi M, Mizushina Y, Kasahara T, Taniguchi S, Muto S, Nagata D and Takahashi M: Role of NLRP3 Inflammasomes for Rhabdomyolysis-induced Acute Kidney Injury. Sci Rep, 2015; 5: 10901
34. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM and Dixit VD: The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med, 2011; 17: 179-188
35. Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ and Ting JP: Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol, 2011; 12: 408-415
36. β decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol, 2003; 23: 656-660
37. Chi H, Messas E, Levine RA, Graves DT and Amar S: Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: phar-macotherapeutic implications. Circulation, 2004; 110: 1678-1685
38. Alexander MR, Moehle CW, Johnson JL, Yang Z, Lee JK, Jackson CL and Owens GK: Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. J Clin Invest, 2012; 122: 70-79
39. Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhela-won B, Carpenter SB, Becker CE, Ediriweera HN, Mul-lick AE, Golenbock DT, Stuart LM, Latz E, Fitzgerald KA and Moore KJ: CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol, 2013; 14: 812-820
40. Menu P, Pellegrin M, Aubert JF, Bouzourene K, Tardivel A, Mazzolai L and Tschopp J: Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome. Cell Death Dis, 2011; 2: e137
41. Komohara Y, Fujiwara Y, Ohnishi K, Shiraishi D and Takeya M: Contribution of macrophage polarization to metabolic diseases. J Atheroscler Thromb, 2016; 23: 10-17
42. Rajamaki K, Lappalainen J, Oorni K, Valimaki E, Mati-kainen S, Kovanen PT and Eklund KK: Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One, 2010; 5: e11765
43. Samstad EO, Niyonzima N, Nymo S, Aune MH, Ryan L, Bakke SS, Lappegard KT, Brekke OL, Lambris JD, Damas JK, Latz E, Mollnes TE and Espevik T: Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. J Immunol, 2014; 192: 2837-2845
44. Weber K and Schilling JD: Lysosomes integrate meta-bolic-inflammatory cross-talk in primary macrophage inflammasome activation. J Biol Chem, 2014; 289: 9158-9171
45. L’Homme L, Esser N, Riva L, Scheen A, Paquot N, Piette J and Legrand-Poels S: Unsaturated fatty acids prevent activation of NLRP3 inflammasome in human mono-cytes/macrophages. J Lipid Res, 2013; 54: 2998-3008
46. β secretion and insulin resistance despite obesity. Diabetes, 2015; 64: 2116-2128
47. Zhou R, Yazdi AS, Menu P and Tschopp J: A role for mitochondria in NLRP3 inflammasome activation. Nature, 2011; 469: 221-225
48. β production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol, 2012; 13: 255-263
49. Razani B, Feng C, Coleman T, Emanuel R, Wen H, Hwang S, Ting JP, Virgin HW, Kastan MB and Semen-kovich CF: Autophagy links inflammasomes to atherosclerotic progression. Cell Metab, 2012; 15: 534-544
50. Emanuel R, Sergin I, Bhattacharya S, Turner JN, Epel-man S, Settembre C, Diwan A, Ballabio A and Razani B: Induction of lysosomal biogenesis in atherosclerotic macrophages can rescue lipid-induced lysosomal dysfunction and downstream sequelae. Arterioscler Thromb Vasc Biol, 2014; 34: 1942-1952
51. Guo C, Xie S, Chi Z, Zhang J, Liu Y, Zhang L, Zheng M, Zhang X, Xia D, Ke Y, Lu L and Wang D: Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome. Immunity, 2016; 45: 802-816
52. Pols TW, Nomura M, Harach T, Lo Sasso G, Oosterveer MH, Thomas C, Rizzo G, Gioiello A, Adorini L, Pellic-ciari R, Auwerx J and Schoonjans K: TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab, 2011; 14: 747-757